the aid library

LIST OPTIONS

Filter

575

Clinical management of COVID-19: Living guideline, 18 August 2023

World Health Organisation (WHO) (2023) C_WHO

The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.

Communicating about Vaccination-related Risks

World Health Organisation (WHO) (2023) C_WHO

This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v... more

Download (284)

View PDF (380)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (111)

View PDF (118)

Development Co-operation Report 2020

OECD (2020) CC

The annual Development Co-operation Report brings new evidence, analysis and ideas on sustainable development to members of the OECD Development Assistance Committee (DAC) and the international community more broadly. The objectives are to promote best practices and innovation in development co-ope... more

External Link

The Case for the Digital Transformation of Circulatory Health

World Heart Federation (2020) CC

This paper explores the angles and opportunities of digital health, with a look at digital innovation and its potential to support patients with circulatory diseases. In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ... more

Country cooperation strategy for WHO and Syrian Arab Republic: 2022-2025

World Health Organization WHO (2024) C_WHO

WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s... more

Mpox Multi-country external situation report n. 37

World Health Organisation (WHO) (2024) C_WHO

22 September 2024

Issue Brief Marburg virus disease (MVD)
recommended

The MEDBOX Team (2024) CC

Issue Brief No. 40 provides healthcare professionals with the most relevant treatment guidelines, prevention measures and training material on MVD

Multi-country outbreak of mpox, External situation report #42- 9 November 2024

World Health Organisation (WHO) (2024) C_WHO

This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.

Operational Guidance: Breastfeeding Counselling in Emergencies

Emergency Nutrition Network ENN (2021) C2

Women and children, especially pregnant girls and women, infants and young children and postpartum women, are populations that are extremely vulnerable in emergencies. Breastfeeding provides children with hydration, comfort, connection, high quality nutrition and protection against disease, shieldin... more

Download (1311)

View PDF (3502)

Community Assessment For Public Health Emergency Response (Casper) Toolkit; third edition 3.2
recommended

Centers for Disease Control and Prevention CDC (2019) CC

2nd edition

Download (879)

View PDF (3372)

Humanitarian Needs Assessment: The Good Enough Guide
recommended

Currion, P. The Assessment Capacities Project and Emergency Capacity Building Project (2014) C2

Needs assessment is essential for programme planning, monitoring and evaluation, and accountability, however needs assessment is still a critical weakness of humanitarian response. Organisations need to improve how they do assessments. The Assessment Capacities Project (ACAPS) and the Emergency Capa... more

Download (851)

View PDF (1208)

Disaster Response and Preparedness in Southern Africa - A guide to international tools and services available to governments

UN Office for the Coordination of Humanitarian Affairs (2015)

The Guide has been developed to enhance the knowledge capabilities of NDMAs and their local partners. This is accomplished by exposing them to the existing tools and services developed by the international community to facilitate effective disaster response to any scale of disaster (small, medium an... more

Download (1344)

View PDF (4189)

Africa - Ebola Coordination and Preparedness, Revised Emergency Appeal MDR60002
recommended

International Federation of Red Cross And Red Crescent Societies (2016) C1

External Link

Global Strategy for Women's, Children's and Adolescents' Health, 2016-2030
recommended

Flavia Bustreo, Shyama Kuruvilla, Marleen Temmerman et al Every Woman Every Child (2015) C_WHO

The new Global Strategy aims to achieve the highest attainable standard of health for all women, children and adolescents, transform the future and ensure that every newborn, mother and child not only survives, but thrives.

Zika virus and potential complications: Questions and answers

World Health Organization (WHO) (2016) C_WHO

updated 05 April 2016

Download (386)

View PDF (649)

LACRO Zika Virus Humanitarian Situation Report, 16 March 2016

UNICEF (2016) C1

Download (693)

View PDF (1692)

WHO's response to Zika virus and its associated complications - Report to donors, December 2016

World Health Organization WHO (2017) C_WHO

Download (1080)

View PDF (1274)

Lindungi Diri dari Bencana Kabut Asap

Ministry of Health Republic of Indonesia, WHO (2016) C_WHO

Protect Yourself from the Smoke Fog Disaster ; a Book of Health Crisis Response for School Children in Indonesia

Sudah Siapkah Kita Menghadapi Gempa Bumi?

Ministry of Health Republic of Indonesia, WHO (2016) C_WHO

Guidance book about implementation of health crisis response for school children in Indonesia in facing earthquake as natural disaster

Issue Brief Marburg virus disease (MVD) recommended

Community Assessment For Public Health Emergency Response (Casper) Toolkit; third edition 3.2 recommended

Humanitarian Needs Assessment: The Good Enough Guide recommended

Africa - Ebola Coordination and Preparedness, Revised Emergency Appeal MDR60002 recommended

Global Strategy for Women's, Children's and Adolescents' Health, 2016-2030 recommended

Issue Brief Marburg virus disease (MVD)
recommended

Community Assessment For Public Health Emergency Response (Casper) Toolkit; third edition 3.2
recommended

Humanitarian Needs Assessment: The Good Enough Guide
recommended

Africa - Ebola Coordination and Preparedness, Revised Emergency Appeal MDR60002
recommended

Global Strategy for Women's, Children's and Adolescents' Health, 2016-2030
recommended